Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A BIOTECHNOLOGY STOCK WITH A FUTURE - GENETIC VECTORS -- Ignore unavailable to you. Want to Upgrade?

To: Jim Drewitz who wrote (12)	10/28/1997 12:49:00 PM
From: Jim Drewitz	Read Replies (1) \| Respond to of 52

TO ALL GVEC INVESTORS: In all the gloom of yesterday, GVEC did announce they were granted a European patent for their EpiDNA Picogram Assay test. The patent provides protection for the countries of Austria, Belgium, Switzerland, Germany, Denmark, Spain, France, Great Britian, Greece, Ireland, Luxembourg, Monaco, the Netherlands, Portugal, Sweden and Italy. This is really significant, because of the large number of drug mfgrs. in Europe....who need this test. Jim Drewitz